GT Medical Technologies: Pioneering a New Paradigm for Brain Tumor Radiotherapy

GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.

Westchester Medical Center First in Region to Offer Brain Tumor Therapy That Can Slow Tumor Progression, Lessen Radiation Site Effects and Reduce Frequency of Post-Surgical Treatments

Westchester Medical Center recently became the first neurosurgical oncology program in the Hudson Valley* to offer a targeted therapy for brain tumors that can help delay tumor progression, spare healthy tissue and reduce the number of post-surgical radiation treatments – and the side effects that come along with them.

GammaTile Therapy

The 24 best medical device innovations of 2022

GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.